CRESY
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria
There isn't enough reported data to score CRESY yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
CRESY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Under pressure |
CRESY's profitability is currently strong, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CRESY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.1x | $8.95 | — |
| Cheap | 9.5x | $0.95 | -89% |
| Fair | 11x | $1.05 | -88% |
| Expensive | 11x | $1.13 | -87% |
Historical ranges are pointers, not guarantees.
CRESY's PE is 9.1x, but its earnings don't support one, so it isn't a reliable read right now.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CRESY Forward outlook
There aren't enough analyst estimates for CRESY to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CRESY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | $0.10 | +25% |
| Q2 2024 | $0.08 | -90% |
| Q2 2023 | $0.82 | +257% |
CRESY has the edge over RKLB in the latest year-over-year earnings comparison.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CRESY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $591.7M | +29% |
| Q2 2024 | $460.4M | +790% |
| Q1 2023 | $71.1M | +250% |
| Q4 2022 | $65.4M | +205% |
| Q3 2022 | $46.1M | +126% |
| Q2 2021 | $27.5M | -65% |
| Q2 2020 | $78.5M | +47% |
| Q2 2019 | $53.5M | +112% |
CRESY has the stronger quarterly revenue trend. Revenue is up 804% for CRESY versus up 73% for RKLB.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | 32% | +82 points |
| Q2 2024 | 4.5% | +6.8 points |
| Q2 2023 | -2.9% | N/A |
| Q1 2023 | 9.1% | +200 points |
| Q4 2022 | -50% | -268 points |
| Q3 2022 | -2.3% | +14 points |
| Q1 2022 | -191% | -227 points |
| Q4 2021 | 218% | +230 points |
CRESY's operating margin was 32% last quarter, up 82 points from the same quarter a year ago.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CRESY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $68.3M | +$74.7M |
| Q2 2024 | -$6.3M | -146% |
| Q2 2023 | $13.9M | +780% |
| Q1 2023 | $5.3M | +$6M |
| Q4 2022 | -$21.1M | -2634% |
| Q3 2022 | $5.7M | -41% |
| Q2 2017 | $1.3M | +126% |
CRESY has the stronger cash trend. Its trailing FCF is up 2,658% versus its history, compared with RKLB at down 85%.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CRESY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 3.2x | Elevated |
| Q2 2024 | 11.0x | High |
| Q2 2023 | 11.9x | High |
| Q1 2023 | 2.5x | Moderate |
| Q3 2022 | 1.6x | Healthy |
| Q2 2022 | 3.9x | Elevated |
| Q2 2021 | 6.8x | High |
| Q2 2020 | 5.1x | High |
CRESY's net debt is about 3.2 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRESY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 9.8 | Oversold |
CRESY's weekly RSI is 33 (neutral) and its Stochastic is 10 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CRESY PE vs Industrials Sector
| Metric | CRESY | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 24x | 62% below |
| PE % | 10 | 58 | 48 pts below |
CRESY is trading at 9.1x earnings, a 62% discount to the Industrials sector's median of 24x, though its earnings don't support one.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CRESY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.9 | 18% below |
| 20 week MA | $11.2 | 20% below |
| 50 week MA | $11.5 | 22% below |
| 100 week MA | $11.3 | 21% below |
| 200 week MA | $9.70 | 7.7% below |
CRESY is in a downtrend: it's below all five of its weekly moving averages, and 7.7% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over CRESY on trend strength, trading above more of its moving averages.
CRESY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.05 | $3.82 | -46% |
| 2021 | $3.82 | $4.56 | +19% |
| 2022 | $4.56 | $5.93 | +30% |
| 2023 | $5.93 | $9.40 | +59% |
| 2024 | $9.40 | $12.9 | +37% |
| 2025 | $12.9 | $11.8 | -7.9% |
| 2026 YTD | $11.8 | $8.95 | -24% |
CRESY has finished higher in four of the last six years. It's down 24% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CRESY on returns for 2026, with the stronger performance.